1. A PCP's Guide to Dyslipidemia

3. Current Recommendations ACC/AHA Cholesterol Guidelines/Risk stratification

5. Risk Calculators

6. New Options The PCSK9 Variant Story

7. Patient Follow-Up

8. PCSK9 Inhibitors 2 Key Indications

9. PCSK9 Inhibitors Effects on LDL-C and CV Events

10. Does Reduction in LDL Cholesterol Equal Less Cardiovascular Events
Does Reduction in LDL Cholesterol Equal Less Cardiovascular Events? IMPROVE-IT

11. Case Discussion Understanding FH

12. Case: Patient Failed to Attain Lipid Goal on Statin Monotherapy

13. Pharmacoeconomic Issues

14. Primary Care Management

15. Patient/Drug Selection and Insurance Coverage

16. Consider Cost and Precertification for Highest Risk Patients

17. Summary

18. Abbreviations

19. Abbreviations (cont)